Back to search

France· FR:60493619

ASPRO CAFEINE 500 mg/50 mg, comprimé effervescent sécable

A medicinal product containing acide acétylsalicylique + caféine, registered in France by BAYER HEALTHCARE.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedASPRO CAFEINE 500 mg/50 mg, comprimé …ATC—REGISTER NO.FR:60493619PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACIDE ACÉTYLSALICYLIQUE + CAFÉINE
Manufacturer
BAYER HEALTHCARE
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400933973407
    film(s) thermosoudé(s) aluminium polyéthylène de 20 comprimé(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Acide acétylsalicylique + caféine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acide acétylsalicylique + caféine products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Acedol
  • Belgium · Aspirine Cafeine
  • Czechia · Acylcoffin
  • Germany · Aspirin Coffein, Doppel Spalt Compact
  • Denmark · Treo, Treo Citrus
  • Spain · Aspirina Plus, Cafiaspirina
  • Finland · Treo
  • United Kingdom (Northern Ireland) · Anadin Original, Beechams
  • Hungary · Aspicont
  • Ireland · Anadin Analgesic, Anadin Maximum Strength
  • Iceland · Treo, Treo Citrus
  • Luxembourg · Aspirine Cafeine
  • Poland · Coffepirine Tabletki Od Bólu Głowy, Dampiryna
  • Portugal · Melhoral, Salicylcafeina
  • Sweden · Bamyl Koffein, Fyro

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c694e3ad-576f-428d-8efd-1b129f47d767
GET /v1/drugs/c694e3ad-576f-428d-8efd-1b129f47d767?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60493619",
  "date_amm": "1995-10-24",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "ACIDE ACÉTYLSALICYLIQUE + CAFÉINE",
  "statut_amm": "Autorisation archivée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "comprimé effervescent(e) sécable",
  "voies_administration": "orale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about acide acétylsalicylique + caféine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.